Regional correlation between resting state FDG PET and pCASL perfusion MRI

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 12, 2013, Pages 1909-1914

  Cha, Yoon Hee K ^a,b   Jog, Mayank A ^a,c   Kim, Yoon Chung ^a,c   Chakrapani, Shruthi ^c   Kraman, Stephen M ^c   Wang, Danny J J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAUREATE INSTITUTE FOR BRAIN RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arterial spin labeling; ASL; Glucose metabolism; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN METABOLISM; BRAIN PERFUSION; CORPUS STRIATUM; FEMALE; FRONTAL LOBE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; INSULA; MALE; NERVE CONDUCTION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSEUDO CONTINUOUS ARTERIAL SPIN LABELING; PUTAMEN; SPIN LABELING; TEMPORAL LOBE;

ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; YOUNG ADULT;

EID: 84889082063     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.147     Document Type: Article

References (31)

1. Silverman DH, Phelps ME. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. Mol Genet Metab 2001; 74: 128-138. (Pubitemid 32955154)
2. Huisman MC, van Golen LW, Hoetjes NJ, Greuter HN, Schober P, Ijzerman RG et al. Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner. EJNMMI Res 2012; 2: 63.
3. Bentourkia M, Bol A, Ivanoiu A, Labar D, Sibomana M, Coppens A et al. Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging. J Neurol Sci 2000; 181: 19-28.
4. Fox PT, Raichle ME, Mintun MA, Dence C. Nonoxidative glucose consumption during focal physiologic neural activity. Science 1988; 241: 462.
5. Detre JA, Leigh JS, Williams DS, Koretsky AP. Perfusion imaging. Magn Reson Med 1992; 23: 37-45.
6. Detre JA, Wang J, Wang Z, Rao H. Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Curr Opin Neurol 2009; 22: 348-355.
7. Feng CM, Narayana S, Lancaster JL, Jerabek PA, Arnow TL, Zhu F et al. CBF changes during brain activation: fMRI vs. PET. Neuroimage 2004; 22: 443-446. (Pubitemid 38515853)
8. Ye FQ, Berman KF, Ellmore T, Esposito G, van Horn JD, Yang Y et al. H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 2000; 44: 450-456.
9. Newberg AB, Wang J, Rao H, Swanson RL, Wintering N, Karp JS et al. Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI-PET scanning. Neuroimage 2005; 28: 500-506. (Pubitemid 41443519)
10. Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES et al. Voxellevel comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology 2011; 77: 1977-1985.
11. Lim YM, Cho YW, Shamim S, Solomon J, Birn R, Luh WM et al. Usefulness of pulsed arterial spin labeling MR imaging in mesial temporal lobe epilepsy. Epilepsy Res 2008; 82: 183-189.
12. Ozsunar Y, Mullins ME, Kwong K, Hochberg FH, Ament C, Schaefer PW et al. Glioma recurrence versus radiation necrosis? A pilot comparison of arterial spinlabeled, dynamic susceptibility contrast enhanced MRI, and FDG-PET imaging. Acad Radiol 2010; 17: 282-290.
13. Towgood KJ, Pitkanen M, Kulasegaram R, Fradera A, Soni S, Sibtain N et al. Regional cerebral blood flow and FDG uptake in asymptomatic HIV-1 men. Hum Brain Mapp advance online publication, 12 April 2012; doi:10.1002/hbm.22078.
14. Wu WC, Fernández-Seara M, Detre JA, Wehrli FW, Wang J. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med 2007; 58: 1020-1027. (Pubitemid 350074370)
15. Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magn Reson Med 2008; 60: 1488-1497.
16. Chen Y, Wang DJ, Detre JA. Test-retest reliability of arterial spin labeling with common labeling strategies. J Magn Reson Imaging 2011; 33: 940-949.
17. Wu WC, Jiang SF, Yang SC, Lien SH. Pseudocontinuous arterial spin labeling perfusion magnetic resonance imaging-a normative study of reproducibility in the human brain. Neuroimage 2011; 56: 1244-1250.
18. Jain V, Duda J, Avants B, Giannetta M, Xie SX, Roberts T et al. Longitudinal reproducibility and accuracy of pseudo-continuous arterial spin-labeled perfusion MR imaging in typically developing children. Radiology 2012; 263: 527-536.
19. Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology 2009; 250: 856-866.
20. Alsop DC, Casement M, de Bazelaire C, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage 2008; 42: 1267-1274.
21. Förster S, Grimmer T, Miederer I, Henriksen G, Yousefi BH, Graner P et al. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay. Biol Psychiatry 2012; 71: 792-797.
22. Maldjian JA, Whitlow CT. For the Alzheimer's Disease Neuroimaging Initiative. Whither the Hippocampus? FDG-PET Hippocampal Hypometabolism in Alzheimer Disease Revisited. AJNR Am J Neuroradiol 2012; 33: 1975-1982.
23. Wang J, Alsop DC, Song HK, Maldjian JA, Tang K, Salvucci AE et al. Arterial transit time imaging with flow encoding arterial spin tagging (FEAST). Magn Reson Med 2003; 50: 599-607. (Pubitemid 37082085)
24. He X, Raichle ME, Yablonskiy DA. Transmembrane dynamics of water exchange in human brain. Magn Reson Med 2012; 67: 562-571.
25. Sokoloff L, Reivich M, Kennedy C, Rosiers MHD, Patlak CS, KDEA Pettigrew et al. The [14c] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat1. J Neurochem 1977; 28: 897-916. (Pubitemid 8098854)
26. Fernández-Seara MA, Edlow BL, Hoang A, Wang J, Feinberg DA, Detre JA. Minimizing acquisition time of arterial spin labeling at 3T. Magn Reson Med 2008; 59: 1467-1471. (Pubitemid 351813278)
27. Shepp LA, Vardi Y. Maximum Likelihood Reconstruction for Emission Tomography. J Comput Assist Tomogr 1983; 7: 571.
28. Yavuz M, Fessler JA. Statistical image reconstruction methods for randomsprecorrected PET scans. Med Image Anal 1998; 2: 369-378. (Pubitemid 128499397)
29. Asllani I, Borogovac A, Wright C, Sacco R, Brown TR, Zarahn E. An investigation of statistical power for continuous arterial spin labeling imaging at 1.5 T. Neuroimage 2008; 39: 1246-1256.
30. Parkes LM, Rashid W, Chard DT, Tofts PS. Normal cerebral perfusion measurements using arterial spin labeling: reproducibility, stability, and age and gender effects. Magn Reson Med 2004; 51: 736-743. (Pubitemid 38420450)
31. Stegger L, Martirosian P, Schwenzer N, Bisdas S, Kolb A, Pfannenberg C et al. Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI. Acta Radiol 2012; 53: 1066-1072.